Opioid dependence remains one of the most severe public health challenges worldwide, with millions trapped in cycles of tolerance, withdrawal, and overdose risk. Traditional treatments—methadone, buprenorphine, naltrexone—help many people stabilize, yet a significant number still struggle with persistent cravings, emotional numbness, or repeated relapses even after months or years in recovery programs. In 2025, medically […]